A thermal device includes an inflatable non-perforated blanket, a conduit structure, and a recirculating assembly. The inflatable non-perforated blanket is configured to transport warm air internally. The conduit structure is configured to provide conduit to transport the warm air externally to the inflatable non-perforated blanket. The recirculating assembly is configured to inflate the inflatable non-perforated blanket with the warm air and: (1) to cause the warm air to flow from the first port to the second port in a first direction, and (2) to recirculate the warm air through the conduit structure to flow from the second port to the first port in the first direction. The inflatable non-perforated blanket includes first and second sheets. The first sheet faces ambient air and has a first thermal conductivity. The second sheet faces the subject body and has a second thermal conductivity higher than the first thermal conductivity.

A cryotherapy system can include an erectable apparatus that can be at least partially inflatable, and configured to extend at least partially around a treatment area adapted to contain at least both vaporized cryogen and at least a portion of a user's body to be cryogenically treated; and a cooling system configurable to provide vaporized cryogen to the treatment area.

A convective thermoregulation blanket (204) includes an exterior surface (220), a plurality of interconnected distribution channels (940, 941) and a first inlet opening (1244). A portion of the exterior surface is configured to be in contact with a patient. The interconnected distribution channels are located internal to the convective thermoregulation blanket and include a primary distribution channel (940) having an interior surface. The first inlet opening extends between the exterior surface of the convective thermoregulation blanket and the interior surface of the primary distribution channel to deliver thermal regulated convective air into the primary distribution channel. At least a portion of the primary distribution channel includes a filter material. The filter material filters unfiltered thermal regulated convective air in the primary distribution channel and provides the remaining plurality of distribution channels with filtered thermal regulated convective air.

A thermal pad for controlling a patient's temperature includes first and second chambers defined between interior and exterior layers. The first chamber circulates a temperature controlled fluid from a first inlet to a first outlet. The second chamber is in fluid communication with a port and a plurality of holes defined in the interior layer. Pressurized gas supplied to the second chamber is vented onto the patient to control the microclimate between the patient's skin and the thermal pad. An additional third chamber is provided in some embodiments that urges the thermal pad into contact with the patient when subjected to negative gauge pressure. In other embodiments, a negative gauge pressure chamber is allowed to partially inflate in order to urge the thermal pad into contact with the patient.

A warming device includes a clinical garment with at least one convective apparatus supported on the inside of the garment. Slits are provided in the clinical garment which enables a patient to insert his or her hands inside the clinical garment to be warmed therein by operation of the convective apparatus.

A sequential compression and temperature therapy blanket with a plurality of air chambers is disclosed. The air chambers are filled and released by a valve assembly that may be separate from or integrated within the blanket. The temperature therapy blanket includes a fluid bladder for delivering hot and/or cold therapy to a patient. The temperature therapy blanket may also include an air bladder for providing compression.

Disclosed is a thermoregulation system, including an output port (54), an input port (62), a thermoregulation fluid supply system, an output pump (52) for pumping thermoregulation fluid out through the output port, an input pump (64) for pumping thermoregulation fluid in through the input port, and a pressure control system. The pressure control system is for selectively operating a pressurising element of a personal thermoregulation pack to apply a pressure independently of operation of the input (64) and output (52) pumps.

A cooling compression sleeve device generally comprising three layers, a flexible bottom layer, a flexible middle layer, and a flexible top layer, and two voids, the first void substantially filled with a cooling agent and the second void comprising a selectively inflatable air bladder, which in its preferred form is portable, cleanable, reusable, and useful to provide cooling therapy to the limbs of humans or animals and particularly to the knee, shoulder, and elbow joints.

A method and apparatus are disclosed for regulating a temperature of an esophagus when heat or cold is delivered to a left atrium, the method including altering a heat exchange device from an insertable configuration to a heat exchanging configuration which conforms and corresponds with a cross-section of an inside of the esophagus such that the esophagus is maintained in its natural shape and location. In some embodiments the heat exchange device has a heating/cooling balloon which is inflated to be in the heat exchanging configuration. Some alternative embodiments includes altering the configuration of the balloon to conform to or correspond with the cross section of an esophagus by means other than inflation.

Embodiments of the present invention are directed to the treatment of hypertension, diabetes, obesity, heart failure, end-stage renal disease, digestive disease, urological disease, cancers, tumors, pains, asthma, pulmonary arterial hypertension, and chronic obstructive pulmonary disease by delivering of an effective amount of formulations at desired temperature to target tissue. The formulations include gases, vapors, liquids, solutions, emulsions and suspensions of one or more ingredients. The temperature may enhance safety and efficacy of the formulations for the treatments. The amounts of the formulation and/or energy are effective to injury or damage the tissues to have a benefit of symptom relive.